Quick Answer
MYRIAD GENETICS INC reported Earnings Per Share Diluted of $3.95 (loss) per share for the year ending 2025.
- MYRIAD GENETICS INC showed a decrease of -180.1% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from MYRIAD GENETICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2009 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2009 to 2025), MYRIAD GENETICS INC's Earnings Per Share Diluted has declined by 559.3%.
- Historical annual values: Fiscal year 2025: $3.95 (loss) per share | Fiscal year 2024: $1.41 (loss) per share | Fiscal year 2023: $3.18 (loss) per share | Fiscal year 2022: $1.39 (loss) per share | Fiscal year 2021: $0.35 (loss) per share | Fiscal year 2020: $2.99 (loss) per share | Fiscal year 2020: $2.69 (loss) per share | Fiscal year 2019: $0.06 per share | Fiscal year 2018: $1.85 per share | Fiscal year 2017: $0.25 per share | Fiscal year 2016: $1.60 per share | Fiscal year 2015: $1.07 per share | Fiscal year 2014: $2.25 per share | Fiscal year 2013: $1.77 per share | Fiscal year 2012: $1.30 per share | Fiscal year 2011: $1.10 per share | Fiscal year 2010: $1.54 per share | Fiscal year 2009: $0.86 per share.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: